tiprankstipranks
Trending News
More News >
RegenXBio (RGNX)
NASDAQ:RGNX
US Market

RegenXBio (RGNX) Technical Analysis

Compare
933 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
RegenXBio’s (RGNX) Moving Averages Convergence Divergence (MACD) indicator is 0.34, suggesting RegenXBio is a Buy.
RegenXBio’s (RGNX) 20-Day exponential moving average is 9.41, while RegenXBio’s (RGNX) share price is $9.27, making it a Sell.
RegenXBio’s (RGNX) 50-Day exponential moving average is 8.77, while RegenXBio’s (RGNX) share price is $9.27, making it a Buy.

RegenXBio (RGNX) Pivot Points

Jun 16, 2025, 01:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.51
9.68
9.94
10.12
10.38
10.55
10.81
Fibonacci
9.68
9.85
9.95
10.12
10.28
10.38
10.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

RegenXBio (RGNX) Moving Averages

Jun 16, 2025, 01:14 AM
Period
Simple
Exponential
MA5
9.80Sell
9.70Sell
MA10
9.75Sell
9.64Sell
MA20
9.54Sell
9.41Sell
MA50
8.40Buy
8.77Buy
MA100
7.89Buy
8.52Buy
MA200
8.82Buy
9.32Sell
RegenXBio’s (RGNX) 10-Day exponential moving average is 9.64, while RegenXBio’s (RGNX) share price is $9.27, making it a Sell.
RegenXBio’s (RGNX) 100-Day exponential moving average is 8.52, while RegenXBio’s (RGNX) share price is $9.27, making it a Buy.
RegenXBio’s (RGNX) stock price is $9.27 and RegenXBio’s (RGNX) 50-day simple moving average is 8.40, creating a Buy signal.
RegenXBio’s (RGNX) stock price is $9.27 and RegenXBio’s (RGNX) 100-day simple moving average is 7.89, creating a Buy signal.
RegenXBio’s (RGNX) stock price is $9.27 and RegenXBio’s (RGNX) 200-day simple moving average is 8.82, creating a Buy signal.

RegenXBio (RGNX) Technical Indicators

Jun 16, 2025, 01:14 AM
Name
Value
Implied Action
RSI (14)
50.26
Neutral
STOCH (9,6)
65.56
Neutral
STOCHRSI (14)
63.61
Neutral
MACD (12,26)
0.34
Buy
ADX (14)
17.05
Buy
Williams %R
-56.72
Buy
CCI (14)
2.60
Neutral
ATR (14)
0.94
-
Ultimate Oscillator
44.92
Neutral
ROC
-4.53
Sell
RegenXBio’s (RGNX) Relative Strength Index (RSI) is 50.26, creating a Neutral signal.
RegenXBio’s (RGNX) Trend Strength Indicator (ADX) is 17.05, creating a Buy signal.
RegenXBio’s (RGNX) Commodity Channel Index (CCI) is 2.60, creating a Neutral signal.
RegenXBio’s (RGNX) Price Rate of Change (ROC) is -4.53, creating a Sell signal.

FAQ

Is RGNX a Buy, Hold, or Sell?
Based on RGNX’s technical indicators, RGNX is a Hold.
    What is RGNX’s RSI (14)?
    RGNX’s RSI (14) is 50.26, which suggests RGNX is a Neutral.
      What is RGNX’s MACD?
      RGNX’s MACD is 0.34, which suggests RGNX is a Buy.
        What is RGNX’s 5-day moving average?
        RGNX’s 5-day moving average is 9.80, which suggests RGNX is a Sell.
          What is RGNX’s 20-day moving average?
          RGNX 20-day moving average is 9.54, which suggests RGNX is a Sell.
            What is RGNX’s 50-day moving average?
            RGNX’s 50-day moving average is 8.40, which suggests RGNX is a Buy.
              What is RGNX’s 200-day moving average?
              RGNX’s 200-day moving average is 8.82, which suggests RGNX is a Buy.
                What is RGNX’s Williams % R (14)?
                RGNX’s Williams % R (14) is -56.72, which suggests RGNX is a Buy.
                  What is RGNX’s CCI (14)?
                  RGNX’s CCI (14) is 2.60, which suggests RGNX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis